Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-11-06A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- Controlled Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment of Major Depressive Disorder (The RELIANCE-II Study)
-
CLINICAL_TRIALS study record update · 2025-11-05Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2025-11-03An Open-label, Multicenter Trial to Assess the Safety and Tolerability of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2025-10-30A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety
-
CLINICAL_TRIALS study record update · 2025-10-30HypErthermia as an Additional Treatment for the Biology and Experience of Depression: Study 2
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-10-29A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NBI-1070770 in Adults With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2025-10-29A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-1065845 as Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2025-10-29Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression: A Crossover Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-10-29Combined Internet-Based Cognitive Behavioral Therapy With Transcranial Magnetic Stimulation for Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2025-10-27Treatment of Comorbid Depression and Cognitive Impairment in Older Adults With Neurocognitive Disorders Using Deep Transcranial Magnetic Stimulation (dTMS)
-
CLINICAL_TRIALS study record update · 2025-10-23Resistance Exercise to Treat Major Depression Via Cerebrovascular Mechanisms: Confirming Efficacy and Informing Precision Medicine
-
CLINICAL_TRIALS study record update · 2025-10-23Tracking the Dynamic Trajectory of Behavioral, Physiological, and Neurobiological Stress Responses in Female Adolescents at High and Low Familial Risk for Depression
-
CLINICAL_TRIALS study record update · 2025-10-22Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
-
CLINICAL_TRIALS study record update · 2025-10-22A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Azetukalner in Moderate-to-Severe Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2025-10-21Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
-
CLINICAL_TRIALS study record update · 2025-10-21An Open-Label, Single-Group Study to Evaluate the Efficacy and Safety of SPN-820 in Adults With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2025-10-06Targeting Large-scale Networks in Depression With Real-time fMRI Neurofeedback
-
CLINICAL_TRIALS study record update · 2025-10-02Accelerated Vascular Aging in Midlife as a Mechanism Linking Daily Stress to Cognitive Decline
-
CLINICAL_TRIALS study record update · 2025-10-02Adjunctive Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder: a Randomized, Double-Blind, Placebo-Controlled Study
-
CLINICAL_TRIALS study record update · 2025-09-30Correct Self-identification Program in the Treatment of Depression: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-09-29Probing the Functional and Behavioral Impact of Precision Circuit Modulation in Neuropsychiatric Diseases
-
CLINICAL_TRIALS study record update · 2025-09-29Treatment of Depression in the Elderly With Repetitive Transcranial Magnetic Stimulation (rTMS) Using Theta-burst Stimulation (TBS): Randomized, Double-blind, Sham-controlled, Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-09-26A Randomised, Controlled Trial to Investigate the Effect of a Sixweek Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
-
CLINICAL_TRIALS study record update · 2025-09-25Invasive Decoding and Stimulation of Altered Reward Computations in Depression
-
CLINICAL_TRIALS study record update · 2025-09-23Neurosteroid Metabolism and the Antidepressant Effects of Serotonin Specific Reuptake Inhibitors (SSRI's)